References
- Smijs TG, Schuitmaker HJ. Photodynamic inactivation of the dermatophyte Trichophyton rubrum. Photochem Photobiol. 2003; 77: 556–60
- Vera JR, Cervera LA. Advantages and disadvantages of topical antifungal agents. Rev Esp Quimioter. 2001; 14: 232–7
- Andreas S, Heindl S, Wattky C, Moller K, Ruchel R. Diagnosis of pulmonary aspergillosis using optical brighteners. Eur Respir J. 2000; 15: 407–11
- Ruchel R, Schaffrinski M, Seshan KR, Cole GT. Vital staining of fungal elements in deep-seated mycotic lesions during experimental murine mycoses using the parenterally applied optical brightener Blankophor. Med Mycol. 2000; 38: 231–7
- Brasch J, Kreiselmaier I, Christophers E. Inhibition of dermatophytes by optical brighteners. Mycoses 2003; 46(3–4)120–5
- San-Blas G. The cell wall of fungal human pathogens; its possible role in host-parasite relationships. Mycopathologia. 1982; 79: 159–84
- WWW.inchem.org/document/side/side/FLUORESCENT.pdf
- Rech C, Engh I, Kuck U. Detection of hyphal fusion in filamentous fungi using differently fluorescence-labeled histones. Curr Genet 2007; 52(5–6)259–66
- Raclavsky V, Kopecek P. Effect of the fluorescent brightener Rylux BSU on the cell wall chitin content in Basidiobolus ranarum. Acta Univ Palacki Olomuc Fac Med. 1994; 138: 19–20
- Therese KL, Bagyalakshmi R, Madhavan HN, Deepa P. In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentration of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates. Int J Med Microbiol. 2006; 24: 273–9
- Koga H, Nanjoh Y, Inoue K, Makimura K, Tsuboi R. In vitro activities of antifungal drugs against clinical isolates of T. tonsurans. Nippon Ishinkin Gakkai Zasshi. 2006; 47: 299–304
- Cuevas ME, Seilheimer K. In vitro cytotoxic activity of anthrapyrazole analogues in human prostate DU-145 and testicular NTERA-2 carcinoma cells. Oncol Rep. 2008; 20: 239–44